The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLIX.z

ANCA positivity. Subclinical or with clinical manifestations

Publications

Takase K, Horton SC, Ganesha A, Das S, McHugh A, Emery P, Savic S, Buch MH

What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort.

Annals of the rheumatic diseases 2014 Sep;73;1695-9 — 2014 Sep — 1695-9

Ramos-Casals M, Roberto-Perez-Alvarez , Diaz-Lagares C, Cuadrado MJ, Khamashta MA,

Autoimmune diseases induced by biological agents: a double-edged sword?

Autoimmunity reviews 2010 Jan;9;188-93 — 2010 Jan — 188-93